Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-002036
Filing Date
2021-01-06
Accepted
2021-01-06 16:19:48
Documents
2
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 22493
2 EX-24 DOCUMENT attachment1.htm EX-24 3418
  Complete submission text file 0001209191-21-002036.txt   27294
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, STE 250 SAN DIEGO CA 92130
Business Address
Mancini Marianna (Reporting) CIK: 0001838112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37355 | Film No.: 21510813